Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor

被引:39
|
作者
Perez-Benito, Laura [1 ,2 ]
Doornbos, Maarten L. J. [3 ,4 ]
Cordomi, Arnau [1 ]
Peeters, Luc [3 ]
lavreysen, Hilde [3 ]
Pardo, Leonardo [1 ]
Tresadern, Gary [2 ,3 ]
机构
[1] Univ Autonoma Barcelona, Fac Med, Lab Med Computac, Unitat Bioestadist, Bellaterra 08193, Spain
[2] Janssen Res & Dev, Computat Chem, Calle Jarama 75A, Toledo 45007, Spain
[3] Janssen Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium
[4] Leiden Univ, LACDR, Div Med Chem, POB 9502, NL-2300 RA Leiden, Netherlands
关键词
PHARMACOLOGICAL CHARACTERIZATION; MGLU2; RECEPTOR; AGONIST; IDENTIFICATION; DISCOVERY; BINDING; POTENT; DETERMINANTS; SIMULATIONS; ANTAGONISTS;
D O I
10.1016/j.str.2017.05.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabotropic glutamate (mGlu) receptors are class C G protein-coupled receptors (GPCRs) crucial for CNS function and important drug discovery targets. Glutamate triggers receptor activation from an extracellular domain binding site while allosteric modulators bind in the seven-transmembrane domain. Little is known about how allosteric modulators produce their functional effects at the molecular level. Herewe address this topic with combined experimental and computational approaches and reveal that mGlu receptor allosteric modulators interact with the homologous "trigger switch'' and "transmission switch'' amino acids as seen in class A GPCRs, in short, the characteristic hallmarks of class A agonist activation translate to themGlu allosteric modulator. The proposed "trigger switch'' for the mGlu2 involves the side chains of F643(3.36a.40c), N735(5.47a.47c), and W773(6.48a.50c), whereas the "transmission switch'' involves the Y647(3.40a.44c), L738(5.50a.50c), and T769(6.44a.46c) amino acids. The work has wide impact on understanding mGlu GPCR function and for future allosteric modulator drugs.
引用
收藏
页码:1153 / +
页数:14
相关论文
共 50 条
  • [21] Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization
    Strauss, Alexa
    Gonzalez-Hernandez, Alberto J.
    Lee, Joon
    Abreu, Nohely
    Selvakumar, Purushotham
    Salas-Estrada, Leslie
    Kristt, Melanie
    Arefin, Anisul
    Huynh, Kevin
    Marx, Dagan C.
    Gilliland, Kristen
    Melancon, Bruce J.
    Filizola, Marta
    Meyerson, Joel
    Levitz, Joshua
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [22] Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
    Liauw, Brandon Wey-Hung
    Foroutan, Arash
    Schamber, Michael R.
    Lu, Weifeng
    Afsari, Hamid Samareh
    Vafabakhsh, Reza
    ELIFE, 2022, 11
  • [23] Allosteric activation of metabotropic glutamate receptor 5
    Jojart, Balazs
    Orgovan, Zoltan
    Marki, Arpad
    Pandy-Szekeres, Gaspar
    Ferenczy, Gyorgy G.
    Keseru, Gyorgy M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2624 - 2632
  • [24] Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the μ-opioid receptor
    Schroeder, H.
    Wu, D. -F.
    Seifert, A.
    Rankovic, M.
    Schulz, S.
    Hoellt, V.
    Koch, T.
    NEUROPHARMACOLOGY, 2009, 56 (04) : 768 - 778
  • [25] Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the μ-opioid receptor
    Schroeder, H.
    Koch, T.
    Wu, D-F
    Seifert, A.
    Rankovic, M.
    Schulz, S.
    Hoellt, V.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 623 - 623
  • [26] Allosteric modulation of metabotropic glutamate receptors by chloride ions
    Tora, Amelie S.
    Rovira, Xavier
    Dione, Ibrahima
    Bertrand, Hugues-Olivier
    Brabet, Isabelle
    De Koninck, Yves
    Doyon, Nicolas
    Pin, Jean-Philippe
    Acher, Francine
    Goudet, Cyril
    FASEB JOURNAL, 2015, 29 (10): : 4174 - 4188
  • [27] Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia
    Fraley, Mark E.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (09) : 1259 - 1275
  • [28] Progress in the Developement of Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2
    Trabanco, A. A.
    Cid, J. M.
    Lavreysen, H.
    Macdonald, G. J.
    Tresadern, G.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (01) : 47 - 68
  • [29] Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (06): : 500 - 501
  • [30] Positive allosteric modulation of native metabotropic glutamate 1 receptors
    Kew, JNC
    Knoflach, F
    Mutel, V
    Jolidon, S
    Malherbe, P
    Vieira, E
    Wichmann, J
    Kemp, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135